Humankind Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,328
Closed -$1.3M 42
2025
Q3
$1.3M Buy
13,328
+968
+8% +$100K 0.3% 43
2025
Q2
$1.33M Buy
12,360
+1,571
+15% +$159K 0.32% 42
2025
Q1
$1.09M Sell
10,789
-1,887
-15% -$190K 0.28% 52
2024
Q4
$1.13M Sell
12,676
-654
-5% -$57.6K 0.29% 49
2024
Q3
$1.12M Buy
13,330
+67
+0.5% +$5.28K 0.4% 46
2024
Q2
$1.02M Buy
13,263
+2,598
+24% +$190K 0.27% 51
2024
Q1
$730K Sell
10,665
-1,354
-11% -$87.1K 0.19% 61
2023
Q4
$695K Sell
12,019
-1,081
-8% -$57.7K 0.21% 60
2023
Q3
$692K Buy
13,100
+709
+6% +$37.2K 0.29% 48
2023
Q2
$670K Buy
12,391
+6,277
+103% +$328K 0.26% 50
2023
Q1
$306K Sell
6,114
-529
-8% -$24.9K 0.13% 88
2022
Q4
$307K Sell
6,643
-113
-2% -$4.89K 0.13% 88
2022
Q3
$262K Buy
6,756
+648
+11% +$26K 0.13% 90
2022
Q2
$228K Sell
6,108
-3,695
-38% -$150K 0.11% 97
2022
Q1
$434K Sell
9,803
-4
-0% -$173 0.18% 72
2021
Q4
$417K Buy
9,807
+1,676
+21% +$70.4K 0.53% 62
2021
Q3
$353K Buy
8,131
+632
+8% +$28K 0.54% 62
2021
Q2
$321K Buy
+7,499
New +$315K 0.57% 56

Other funds holding BSX

Humankind Investments's BSX Position: Q4 2025 in Review

Humankind Investments sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 13,328 shares — an estimated $1.3M sold.

Humankind Investments first reported a position in BSX in Q2 2021 and held it in 18 quarters. The position peaked at $1.33M in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Humankind Investments reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 13,328 Boston Scientific shares in Q4 2025, an estimated $1.3M.
  • Humankind Investments first reported a position in Boston Scientific in Q2 2021 and held it in 18 quarters.
  • Humankind Investments's Boston Scientific position peaked at $1.33M in Q2 2025.
  • 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.